Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial - Bissler, J J; Kingswood, J C; Radzikowska, E (Lancet, 2013)
et al.